Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Katherine Kendrick
Safety Surveillance Research, Pfizer, Inc.
Poster(s):
(344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
